Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier Cancer Trialnews2024-08-12T12:32:17+00:00August 12th, 2024|Medical Device News Magazine|
New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networksnews2024-07-25T15:10:37+00:00July 25th, 2024|Medical Device News Magazine|
Trial Approval for New Pacemaker Aiming to Boost Recovery in Heart Failurenews2024-07-23T13:06:17+00:00July 23rd, 2024|Medical Device News Magazine|
Enterprise Therapeutics Doses First Person with Cystic Fibrosis in Phase 2 Trial for Novel Therapy ETD001news2024-07-23T10:33:20+00:00July 23rd, 2024|Medical Device News Magazine|
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemianews2024-07-22T13:52:41+00:00July 22nd, 2024|Medical Device News Magazine|
Blood Filtration Offers Hope in the Fight Against Pancreatic Cancernews2024-07-18T17:44:22+00:00July 18th, 2024|Medical Device News Magazine|
Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBCnews2024-07-15T14:45:42+00:00July 15th, 2024|Medical Device News Magazine|
Phage-Derived Enzyme Targets E. faecalis Biofilms to Mitigate Acute Graft-Versus-Host Diseasenews2024-07-11T06:03:36+00:00July 11th, 2024|Medical Device News Magazine|
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’news2024-07-01T06:45:36+00:00July 1st, 2024|Medical Device News Magazine|
PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Veranews2024-06-25T17:02:37+00:00June 25th, 2024|Medical Device News Magazine|
